from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2261c/-

LFCtreatmentdescriptionclass of inhibitor

-0.809

Amikacinug/mL Amikacintranslation

-0.155

Cap5-10ug/mL Capreomycintranslation

-0.859

Rox10-50 ug/mL Roxithromycintranslation

-0.306

SM2-5 ug/mL Streptomycintranslation

0.973

Tet5-10 ug/mL Tetracyclinetranslation

0.887

Rif0.2-5ug/mL Rifampicintranscription

-0.011

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.712

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.283

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.442

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.135

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.825

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.241

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.315

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.383

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.204

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.167

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.279

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.886

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.350

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.135

KCN5-20 ug/mL Potassium cyaniderespiration

-0.824

NaN30.2-2 mM Sodium aziderespiration

-1.314

Nigericin50 uM Nigericinrespiration

0.482

TRC10-150 ug/mL Triclosanrespiration

0.760

TRZ10-25 ug/mL Thioridazinerespiration

-0.815

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.573

menadione6-10 ug/mL Menadionerespiration

0.106

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.832

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.920

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.191

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.468

NRP_1Non-replicating persistence stage 1dosRassociated

-1.034

Amp0.2mg/mL AmpicillincellWall

-0.418

Cephalexin20-100 ug/mL CephalexincellWall

-0.052

Cerulenin0.32-5 ug/mL CerulenincellWall

0.374

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.257

EMB10-20 ug/mL EthambutolcellWall

0.726

Eta12-40 ug/mL EthionamidecellWall

0.529

INH0.2-0.4 ug/mL IsoniazidcellWall

1.560

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.436

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.636

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.313

BZA0.12 mg/mL BenzamidearomaticAmides

0.310

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.065

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.050

H2O24 mM hydrogen peroxideDNAdamaging

-0.495

Levo10 ug/mL LevofloxacinDNAdamaging

0.275

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.543

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.122

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.284

UVUV-irradiationDNAdamaging

-0.196

ARP41-4 ug/mL Antitubercular compound ARP4?

0.376

Antimycin12.5-50 ug/mL Antimycin A?

-0.657

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.318

PA_110-50 ug/mL Antitubercular compound PA-1?

0.298

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.461

PA8240.2-2 ug/mL PA-824?

-0.541

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.032

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.432

Verapamil50 uM Verapamil?

-0.556

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.950

methoxatin10-20 ug/mL Methoxatin?